Sign in

CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company

Chemomab Therapeutics Ltd.

Sign in to watch
Ticker
CMMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
EIN
813676773
Phone
972-77-331-0156
Business address
KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
Former names
Anchiano Therapeutics Ltd., BioCancell Ltd.
  1. UPLOAD Other SEC-generated Letter
  2. DEF 14A Proxy Proxy Statement
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. SC 13D/A Stake Beneficial Ownership Report
  5. PRE 14A Proxy Proxy Statement (Preliminary)
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. 10-K Report Annual Report
  8. 8-K Event Other events
  9. 8-K Event Executive or director change · Other events
  10. 8-K Event Exit or restructuring costs · Regulation FD disclosure
  11. 8-K Event Other events
  12. SC 13D/A Stake Beneficial Ownership Report
  13. 8-K Event Other events
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 8-K Event Executive or director change · Other events
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 14 of 19 · 368 filings